Skip to main content

Incannex Healthcare Inc.

IXHL
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001873875

No open-market purchases or sales by Incannex Healthcare Inc. insiders were filed in the last 90 days; 15 institutions reported holding it in 13F filings for Q2 2026, worth $1.71M in total; no superinvestor holds it.

Q1 2024 vs. Q4 2023

How the institutions holding Incannex Healthcare Inc. changed between Q4 2023 and Q1 2024.

All holders in Q1 2024All holders in Q4 2023

13F holders of IXHL: Q4 2023 compared with Q1 2024
MeasureQ4 2023Q1 2024Change
Holders615+9
Shares272.6K640.7K+368.1K (+135.0%)
Value$1.26M$2.30M+$1.03M (+81.6%)

New holders (12)

Institutions that held Incannex Healthcare Inc. at the end of Q1 2024 but not at the end of Q4 2023.

Institutions new to IXHL in Q1 2024
InstitutionSharesValue% of portfolio
Toroso Investments, LLC423,410$1.52M0.03%
HRT Financial LP82,972$297.0K0.00%
Morgan Stanley29,848$107.2K0.00%
Jane Street Group, LLC20,435$73.4K0.00%
Virtu Financial LLC10,806$39.0K0.00%
UBS Group AG2,924$10.5K0.00%
Qube Research & Technologies Ltd2,101$7.54K0.00%
Bank of America Corp804$2.89K0.00%
Catalyst Funds Management Pty Ltd50$1800.00%
JPMorgan Chase & Co10$360.00%
Barclays PLC2$70.00%
Macquarie Group Ltd598$20.00%

Sold out (3)

Institutions that held Incannex Healthcare Inc. at the end of Q4 2023 and filed for Q1 2024 without it.

Institutions that sold out of IXHL in Q1 2024
InstitutionShares, Q4 2023Value, Q4 2023
Vanguard Group Inc114,051$529.2K
Mirae Asset Global Investments Co., Ltd.81,747$379.3K
Millennium Management LLC21,733$100.8K